BrandEseence Logo

Continuous Glucose Monitoring (CGM) Market

Continuous Glucose Monitoring (CGM) Market Size, Share & Trends Analysis Report

Continuous Glucose Monitoring (CGM) Market Outlook, Opportunity And Demand Analysis Report 2020 To 2025

MethodologyRequest MethodologyMethodologyDownload Sample
Published
Report ID : BMRC 363
Number of pages : 300
Published Date : Nov 2022
Category : Healthcare
Delivery Timeline : 48 hrs
PricingPricing

Global Continuous Glucose Monitoring (CGM) Market is valued at USD 575.65 Million in 2018 and expected to reach USD 1337.59 Million by 2025 with the CAGE of 12.80% over the forecast period.

Scope of Global Continuous Glucose Monitoring (CGM) Market Reports –

Continuous Glucose Monitoring (CGM) is an advanced way for people living with diabetes to check glucose readings in real-time or monitor glucose readings over a period of time. By using a continuous glucose monitor, patient CGM system will automatically receive glucose readings every 5 minutes allowing patient to fingerstick less often. CGM can be castoff with or without an insulin pump.  A small, reusable transmitter connects to the sensor wire and sends real-time readings wirelessly to a receiver, so the operator can view the information. With some systems, a well-suited smart device with the CGM system app can serve as the display device. The receiver or compatible clever device displays current glucose levels, as well as historical trends in levels.

Global continuous glucose monitoring (CGM) market report is segmented on the basis of component type, end-user and by regional & country level. Based on component type, global continuous glucose monitoring (CGM) market is classified as transmitters & receivers, sensors, and insulin pumps. Based upon end-user, global continuous glucose monitoring (CGM) market is classified into hospitals, homecare diagnostics, and others.

The regions covered in this continuous glucose monitoring (CGM) market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of continuous glucose monitoring (CGM) is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players -

Global continuous glucose monitoring (CGM) market report covers prominent players like Pfizer Inc., Ypsomed, Baxter International Inc., Novo Nordisk, Abbott Laboratories, Animas Corporation, Medtronic, Inc. Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., Insulet Corporation, GlySens Incorporated, Johnson & Johnson, Senseonics Holdings, Inc., F. Hoffmann-La Roche Ltd. and others.

Market Dynamics –

The global continuous glucose monitoring industry is   driven by increasing number of people suffering from diabetes that demands continuous monitoring of the glucose level. For instance, according to the International Diabetes Federation, the number of people suffering from diabetes was 415 million in 2015, which is expected to reach approximately 640 million by 2040. As per WHO data, approximately half of all mortality can be associated with high blood glucose occur before the age of 70 years. However, high cost and low availability of CGM systems in the developing countries can hinder the growth of CGM market during the forecast period. Additionally, rising need for the diagnosis of hyperglycemic and hypoglycemic conditions in an individual, and increasing need of research and development by the key players would create lucrative opportunities in the market.

Regional Analysis –

North America dominates the Continuous Glucose Monitoring (CGM) market due to the large patient pool and wide acceptance of advanced technologies.

Europe holds the second position in the market. The growth of continuous glucose monitoring (CGM) devices market in Europe is primarily due to the high penetration of smartphones, and increasing number of diabetic patients in the region.

Asia-Pacific has a huge market potential for continuous glucose monitoring (CGM). As per the Asian Diabetes Prevention Initiative, practically 60% of the world's diabetic population resides in the Asia Pacific region. However, high commonness of the infection in emerging nations, for example, India and China has been pushing market development in the region.

Key Benefits for Market Reports –

  • Global Continuous Glucose Monitoring (CGM) Market report covers in depth historical and forecast analysis.
  • Global Continuous Glucose Monitoring (CGM) Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Continuous Glucose Monitoring (CGM) Market report helps to identify opportunities in market place.
  • Global Continuous Glucose Monitoring (CGM) Market report covers extensive analysis of emerging trends and competitive landscape.

Market Segmentation –

By Component Type analysis

  • Transmitters & Receivers
  • Sensors
  • Insulin Pumps

By End User analysis

  • Hospitals
  • Homecare Diagnostics
  • Others

Regional & Country Analysis

  • North America
    • US.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

 

SUMMARY
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
Book Appointment
Book 15 min Free Analyst Call
Segmentation
Segments

By Component Type analysis

  • Transmitters & Receivers
  • Sensors
  • Insulin Pumps

By End User analysis

  • Hospitals
  • Homecare Diagnostics
  • Others
Country
Regions and Country

North America

  • U.S.
    U.S.
  • Canada
    Canada

Europe

  • Germany
    Germany
  • France
    France
  • U.K.
    U.K.
  • Italy
    Italy
  • Spain
    Spain
  • Sweden
    Sweden
  • Netherlands
    Netherlands
  • Turkey
    Turkey
  • Switzerland
    Switzerland
  • Belgium
    Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
    South Korea
  • Japan
    Japan
  • China
    China
  • India
    India
  • Australia
    Australia
  • Philippines
    Philippines
  • Singapore
    Singapore
  • Malaysia
    Malaysia
  • Thailand
    Thailand
  • Indonesia
    Indonesia
  • Rest of APAC

Latin America

  • Mexico
    Mexico
  • Colombia
    Colombia
  • Brazil
    Brazil
  • Argentina
    Argentina
  • Peru
    Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
    Saudi Arabia
  • UAE
    UAE
  • Egypt
    Egypt
  • South Africa
    South Africa
  • Rest of MEA
Company
Key Players
  • Pfizer Inc.,
  • Ypsomed,
  • Baxter International Inc.,
  • Novo Nordisk,
  • Abbott Laboratories,
  • Animas Corporation,
  • Medtronic, Inc.
  • Dexcom, Inc.,
  • A. Menarini Diagnostics,
  • Echo Therapeutics, Inc.,
  • Insulet Corporation,
  • GlySens Incorporated,
  • Johnson & Johnson,
  • Senseonics Holdings, Inc.,
  • F. Hoffmann-La Roche Ltd. and others.

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)
+44-1173181773 - U.K. OFFICE
+91-7447409162 - INDIA OFFICE

© Copyright 2023-24 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes